Abstract |
A lucanthone, one of the family of thioxanthenones, has been reported for its inhibitory effects of apurinic endonuclease-1 and autophagy. In this study, we investigated whether lucanthone could enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in various cancer cells. Combined treatment with lucanthone and TRAIL significantly induced apoptosis in human renal carcinoma (Caki and ACHN), prostate carcinoma (PC3), and lung carcinoma (A549) cells. However, combined treatment did not induce apoptosis in normal mouse kidney cells (TCMK-1) and normal human skin fibroblast (HSF). Lucanthone downregulated protein expression of deubiquitinase DUB3, and a decreased expression level of DUB3 markedly led to enhance TRAIL-induced apoptosis. Ectopic expression of DUB3 inhibited combined treatment with lucanthone and TRAIL-induced apoptosis. Moreover, lucanthone increased expression level of DR5 mRNA via downregulation of miR-216a-5p. Transfection of miR-216a-5p mimics suppressed the lucanthone-induced DR5 upregulation. Taken together, these results provide the first evidence that lucanthone enhances TRAIL-induced apoptosis through DR5 upregulation by downregulation of miR-216a-5p and DUB3-dependent Mcl-1 downregulation in human renal carcinoma cells.
|
Authors | Ji Yun Yoon, Seon Min Woo, Seung Un Seo, So Rae Song, Seul Gi Lee, Taeg Kyu Kwon |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 23
Issue 1
(Dec 21 2021)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 35008442
(Publication Type: Journal Article)
|
Chemical References |
- MCL1 protein, human
- MIRN216 microRNA, human
- MicroRNAs
- Myeloid Cell Leukemia Sequence 1 Protein
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- TNF-Related Apoptosis-Inducing Ligand
- TNFRSF10B protein, human
- Endopeptidases
- USP17L2 protein, human
- Lucanthone
|
Topics |
- A549 Cells
- Animals
- Autophagy
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Down-Regulation
- Drug Synergism
- Endopeptidases
(metabolism)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Lucanthone
(pharmacology)
- Mice
- MicroRNAs
(genetics)
- Myeloid Cell Leukemia Sequence 1 Protein
(genetics, metabolism)
- Neoplasms
(drug therapy, genetics, metabolism)
- PC-3 Cells
- Receptors, TNF-Related Apoptosis-Inducing Ligand
(genetics)
- TNF-Related Apoptosis-Inducing Ligand
(pharmacology)
- Up-Regulation
|